- Home
- LNZA vs NTRB Comparison
LNZA vs NTRB Comparison
Compare LNZA & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- NTRB
- Stock Information
- Founded
- LNZA 2005
- NTRB 2016
- Country
- LNZA United States
- NTRB United States
- Employees
- LNZA N/A
- NTRB N/A
- Industry
- LNZA Major Chemicals
- NTRB Industrial Specialties
- Sector
- LNZA Industrials
- NTRB Health Care
- Exchange
- LNZA Nasdaq
- NTRB Nasdaq
- Market Cap
- LNZA 98.1M
- NTRB 87.2M
- IPO Year
- LNZA N/A
- NTRB N/A
- Fundamental
- Price
- LNZA $24.23
- NTRB $7.33
- Analyst Decision
- LNZA Hold
- NTRB Buy
- Analyst Count
- LNZA 2
- NTRB 1
- Target Price
- LNZA $200.00
- NTRB $13.00
- AVG Volume (30 Days)
- LNZA 27.5K
- NTRB 32.3K
- Earning Date
- LNZA 11-07-2025
- NTRB 09-09-2025
- Dividend Yield
- LNZA N/A
- NTRB N/A
- EPS Growth
- LNZA N/A
- NTRB N/A
- EPS
- LNZA N/A
- NTRB N/A
- Revenue
- LNZA $40,540,000.00
- NTRB $2,578,059.00
- Revenue This Year
- LNZA N/A
- NTRB $560.75
- Revenue Next Year
- LNZA $86.24
- NTRB $588.39
- P/E Ratio
- LNZA N/A
- NTRB N/A
- Revenue Growth
- LNZA N/A
- NTRB 42.92
- 52 Week Low
- LNZA $14.01
- NTRB $2.98
- 52 Week High
- LNZA $274.00
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- LNZA 51.43
- NTRB 65.18
- Support Level
- LNZA $22.01
- NTRB $6.82
- Resistance Level
- LNZA $25.93
- NTRB $7.49
- Average True Range (ATR)
- LNZA 3.78
- NTRB 0.42
- MACD
- LNZA 0.80
- NTRB 0.07
- Stochastic Oscillator
- LNZA 54.04
- NTRB 91.94
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.